Allylanisole

Allylanisole and pregnancy

Not Recommended

• Absorbed into the body
• Fetal development

Allylanisole (estragole) is a fragrance compound that belongs to the phenylpropene family, which includes other compounds that have raised concerns during pregnancy. While used in small amounts in perfuming, it can be absorbed through the skin. Animal studies have shown that estragole can cross the placental barrier and may affect fetal development at high doses. According to the European Commission's Scientific Committee, estragole has demonstrated potential hepatotoxicity and developmental concerns in animal studies, though these used doses much higher than would be encountered in cosmetic use. However, due to the potential for accumulation with repeated use and concerns about metabolic conversion to potentially harmful compounds, many toxicologists recommend a precautionary approach during pregnancy, particularly in the first trimester when organ development occurs. While cosmetic products contain estragole at much lower concentrations than those shown to cause harm in animal studies, the principle of minimizing exposure to potentially concerning compounds during pregnancy is widely endorsed by obstetricians. ACOG generally recommends limiting exposure to unnecessary chemical fragrances during pregnancy. Given that this is a fragrance ingredient with no skincare benefit, avoiding products containing it during pregnancy is a reasonable precaution.

Allylanisole and breastfeeding

Safe to Use

• Common allergen

While estragole can be absorbed through the skin, topical cosmetic use results in minimal systemic exposure. Studies on essential oils containing estragole suggest that topical application leads to limited absorption compared to oral intake. There is insufficient data on the transfer of estragole into breast milk from topical cosmetic use. Given the low concentrations used in perfuming and topical application, significant milk transfer is unlikely. However, some essential oil compounds can transfer to breast milk, so caution is warranted with repeated application of products containing this ingredient, especially near the breast area. The primary concern during breastfeeding is more about potential allergic reactions in the mother than infant exposure. If using products containing allylanisole, avoid application on or near breasts to minimize any potential for infant exposure during breastfeeding.

Allylanisole and postpartum

Safe to Use

• Common allergen

For postpartum women not breastfeeding, the main concern with allylanisole is its potential as a fragrance allergen rather than systemic toxicity. Postpartum skin may be more sensitive, making allergic reactions more likely. While animal studies have raised concerns about high-dose exposure, the low concentrations used in cosmetic fragrances are not expected to cause systemic effects in healthy adults. However, given that this is a non-essential fragrance ingredient, those with sensitive skin may prefer to avoid it.

Allylanisole and trying to conceive

Caution Advised

• Absorbed into the body

Given the concerns about estragole during pregnancy, particularly in early development, it's prudent to begin avoiding products containing this ingredient when actively trying to conceive. This allows time for any accumulated compound to clear before conception occurs. While there's no direct evidence that topical cosmetic exposure to allylanisole affects fertility, the precautionary principle suggests minimizing exposure to ingredients that raise developmental concerns. Switching to fragrance-free or naturally-fragranced alternatives during the trying-to-conceive period is a reasonable approach.

Allylanisole and PCOS

Safe to Use

• Common allergen

Allylanisole has no known effects on androgen levels, insulin sensitivity, or other metabolic markers associated with PCOS. It does not interfere with hormonal balance in the context of PCOS management. The primary consideration for individuals with PCOS is the ingredient's potential to cause allergic reactions, which could contribute to skin inflammation. Since PCOS often involves inflammatory skin conditions like acne, minimizing potential irritants is beneficial. There is no evidence that estragole affects the endocrine disruptions specific to PCOS. However, as a fragrance ingredient with allergenic potential, those with sensitive or acne-prone skin associated with PCOS may choose to avoid it.

Allylanisole and general use

Safe to Use

• Common allergen

Allylanisole (estragole) is used in small amounts as a fragrance ingredient in cosmetics. For the general population, the main concern is its classification as a fragrance allergen that can cause skin sensitization in susceptible individuals. According to ECHA and the EU Cosmetics Regulation, estragole must be listed on ingredient labels when present above 0.001% in leave-on products or 0.01% in rinse-off products due to its allergenic potential. IFRA has set recommended maximum use levels to minimize sensitization risk. While animal studies have raised concerns about potential toxicity at high oral doses, the concentrations used in cosmetic fragrancing are considered safe for topical use in the general population. Individuals with fragrance sensitivities, allergies, or sensitive skin may want to avoid products containing this ingredient. For most healthy adults, occasional use in cosmetics at regulated concentrations is not expected to cause adverse effects, though fragrance-free options are available for those who prefer to minimize exposure.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in trying to conceive

Related ingredients

Ingredients that raise the same concerns.

• Benzophenone-4Fetal development, Common allergen, Absorbed into the body
• Benzophenone-3Fetal development, Common allergen, Absorbed into the body
• Arnica Montana Flower ExtractFetal development, Common allergen, Absorbed into the body
• Anthemis Nobilis Flower OilFetal development, Common allergen, Absorbed into the body
• Cocamide DEAFetal development, Common allergen, Absorbed into the body
• Artemisia Vulgaris ExtractFetal development, Common allergen, Absorbed into the body

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.